Dr. Pigarelli's clinical research interests include clinical and quality of life outcomes of drug therapy and pharmaceutical care; her academic research interests include outcomes related to instructional design and assessment.

Background: Denise completed a specialty practice residency in ambulatory care at the William S. Middleton Memorial VA Hospital in Madison, Wisconsin in 1994, and she practiced as a primary care clinical pharmacist at the Carl T. Hayden VAMC in Phoenix, Arizona before joining the School of Pharmacy in 1996. Professor Pigarelli currently practices at the Madison VA in Diabetes Clinic; her main pharmacotherapeutic interests include diabetes, hypertension, and hyperlipidemia.

Professional Interests: Diabetes, hypertension, hyperlipidemia

Education:

• BS 1991 - University of Wisconsin
• PharmD 1993 - University of Wisconsin
• -

Course coordinator and instructor:

• PHARM 125: Exploring Pharmacy I (co-coordinator)
  
• PHARM 126: Exploring Pharmacy II (co-coordinator)
• PHM PRAC 305: Consumer Self-Care & OTC Drugs (coordinator)
  
• PHM PRAC 490: FIG Peer Mentor/TA Seminar (co-coordinator)
• PHM PRAC 638: Nonprescription Products & Self-Care (coordinator)
• PHM PRAC 679: Advanced Diabetes Management (coordinator)
• PHM PRAC 760: Advanced Pharmaceutical Care Clerkship (co-coordinator)

Course instructor:

• PHM PRAC 461: Pathways in Pharmacy Practice
• PHM PRAC 625: Introductory Pharmacy Practice Experience V
• PHM PRAC 653: Integrated Skills Lab
• PHM PRAC 655: Pharmacotherapy III
• PHY ASST 660: Clinical Skills
  

Denise practices at the Madison VA in Diabetes Clinic under a scope of practice as a clinical pharmacy specialist.

• Walbrandt Pigarelli DL, Musil B. 2012 update: new drugs for glycemic control in type 2 diabetesmellitus. Journal of the Pharmacy Society of Wisconsin. 2012;15(4): 24-34.
• Walbrandt Pigarelli DL. Commentary:  Stop diabetes—now! Journal of the Pharmacy Society of Wisconsin. 2011;14(6).
• Walbrandt Pigarelli DL. PSW endorses Wisconsin diabetes strategic plan.  Journal of the Pharmacy Society of Wisconsin. 2011;14(4):31-32.
• Mannebach C, Walbrandt Pigarelli DL. Safer A1c range in outpatients with type 2 diabetes. Journal of the Pharmacy Society of Wisconsin. 2011;14(3):44-45.
• Wisconsin Diabetes Mellitus Essential Care Guidelines. (Rev. 3/11) Section 4: Glycemic control. Wisconsin Department of Health Services Web site. http://www.dhs.wisconsin.gov/health/diabetes/guidelines.htm. Updated  August 23, 2011.  Accessed August 29, 2011.
• Musil BA, Walbrandt Pigarelli DL. New drugs for glycemic control in type 2 diabetes mellitus. Recently-approved and pipeline drugs for treatment of type 2 diabetes. Journal of the Pharmacy Society of Wisconsin. 2010; September/October:16-24.
• Walbrandt Pigarelli DL. We’ve come a long way, baby! Evolution of the pharmacist’s role in community diabetes pharmacy practice. Journal of the Pharmacy Society of Wisconsin. 2010; May/June:60.
• Walbrandt Pigarelli DL. Alphabet soup: A1c or eAG? A new tool for impacting diabetes outcomes. Journal of the Pharmacy Society of Wisconsin. 2009; March/April:20.
• Wisconsin Diabetes Mellitus Essential Care Guidelines. (Rev. 8/08) Section 4: Glycemic control. Wisconsin Department of Health Services Web site. http://dhs.wisconsin.gov/health/diabetes/guidelines.htm. Updated February 5, 2009.  Accessed February 13, 2009.
• Walbrandt Pigarelli DL. Insulin sensitizers for non-alcoholic fatty liver disease in type 2 diabetes mellitus. Which drug is preferred? Journal of the Pharmacy Society of Wisconsin. 2007;November/December:26-27.
• Johnson KL, Walbrandt Pigarelli DL. Testosterone for hypoactive sexual desire disorder. Evid Based Pract. 2007;10(6):5,7.
• WalbrandtPigarelli DL. OTC product: Citracal creamy bites. JAPhA. 2007;47:304.
• Walbrandt Pigarelli DL. Insulin initiation and titration. Inpatient and outpatient insulin dosing methods. Journal of the Pharmacy Society of Wisconsin. 2007;January/February:25-28.
• Schiedermayer D, Walbrandt Pigarelli DL. Is oral alpha-galactosidase effective in treating in gas symptoms from beans in the diet? Evid Based Pract. 2006;9(12):8,12.
• Walbrandt Pigarelli DL. Gatifloxacin removed from market. Journal of the Pharmacy Society of Wisconsin. Journal of the Pharmacy Society of Wisconsin. 2006;September/October:35.
• Walbrandt Pigarelli DL. OTC product: SudaCareshower soothers. JAPhA. 2006;46:528.
• Haslow KD, Walbrandt Pigarelli DL. Gabapentin vs pregabalin for p ainful diabetic peripheral neuropathy. Journal of the Pharmacy Society of Wisconsin. 2006;July/August:16-17.
• Motszko A, Walbrandt Pigarelli DL. Do acupressure wrist bands prevent motion sickness? Evid Based Pract. 2006;9(6):7-8.
• Staresinic AG, Sorkness CA, Goodman BM, Walbrandt Pigarelli D. Comparison of outcomes using two delivery models of anticoagulation care. Arch Intern Med. 2006;166:997-1002.
• Vasys KM, Walbrandt Pigarelli DL. Are selective serotonin reuptake inhibitors associated with gastrointestinal bleed in adults? Evid Based Pract. 2006;9(4):4-5.
• Hansen LA, Walbrandt Pigarelli DL. How safe and effective is bupropion in the treatment of femal sexual dysfunction secondary to the use of selective serotonin reuptake inhibitors (SSRIs)?.  Evid Based Pract. 2006;9(3):4-5.
• Murphy EM, Walbrandt Pigarelli DL.  How safe and effective is glyburide in the treatment of gestational diabetes mellitus? Evid Based Pract. 2006;9(1):6-7.
• Walbrandt Pigarelli DL. Advanced Practice Institute: Diabetes, an update on type 2 diabetes. American Pharmacists Association Foundation. 2004;November:1-8.
• Walbrandt Pigarelli DL. A true challenge. Journal of the Pharmacy Society of Wisconsin. 2004; March/April:4-5.
• Hermansen CJ, Walbrandt Pigarelli D, Sorkness CA, Wiederholt JB. The patient perspective of pharmacy clerkship students’ roles in pharmacist-patient relationship development and the delivery of care. Am J Pharm Educ. 2000;64:413-419.
• Pigarelli DW, Boh LE. The one minute counselor: a pharmacist’s guide to managing patients with osteoarthritis receiving acetaminophen or NSAIDs.  The one minute counselor: a patient’s guide to managing osteoarthritis with acetaminophen and NSAIDs.  J Am Pharm Assoc.  2000;40:437-438, correction 453.

Book Chapters

• Walbrandt Pigarelli DL, Kraus CK, Potter B. Pregnancy and lactation: therapeutic considerations. In: DiPiro JT, Talbert RL, Yee GC, et al; eds. Pharmacotherapy: A Pathophysiologic Approach. 7^th ed. Chicago: McGraw-Hill. 2008:1297-1311.
• Walbrandt Pigarelli DL, Kraus CK, Potter B. Pregnancy and lactation: therapeutic considerations. In: DiPiro JT, Talbert RL, Hayes PE, et al; eds. Pharmacotherapy: A Pathophysiologic Approach. 6^th ed. Chicago: McGraw-Hill. 2005:1425-1442.
• Fay MA, Walbrandt Pigarelli DL. Myopathies. In: Drug-Induced Diseases: Prevention, Detection, and Management. American Society of Health-System Pharmacists. 2005: 721-730.
• Walbrandt Pigarelli DL, Kraus CK. Pregnancy and lactation: therapeutic considerations. In: DiPiro JT, Talbert RL, Hayes PE, et al; eds. Pharmacotherapy: A Pathophysiologic Approach. 5^th ed. Chicago: McGraw-Hill. 2002:1413-1430.
• Martin BA, Walbrandt Pigarelli DL. Home test kits and monitoring devices. In: Pharmacy Practice Manual: A Guide to the Clinical Experience. 2^nd ed. Philadelphia: Lippincott Williams & Wilkins;2001.
• Schuna AA, Schmidt MJ, Walbrandt Pigarelli DL. Rheumatoid arthritis. In: DiPiro JT, Talbert RL, Hayes PE, et al; eds. Pharmacotherapy: A Pathophysiologic Approach. 4th ed.  New York: Elsevier; 1999.